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Somatostatin (SST), a tetradecapeptide, is considered to be 
one of the important neuromodulators in the central nervous 
system (E p e l b a u m , 1994). It is present in the central ner-
vous system (R e u b i , 1997), the hypothalamopituitary system, 
the gastrointestinal tract, the exocrine and endocrine pancreas, 
and the immune system (R e i c h l i n ,  1983). In the central 
nervous system, SST is mainly distributed in the cerebral cor-
tex, hippocampus, and hypothalamus (C h a n - P a l a y ,  1987; 
J o h a n s s o n  et al., 1984). It is well known that the cerebral 
cortex and hippocampus are integrative regions of cognitive 
functions. Considerable effort has been made to investigate the 
behavioral, neuropharmacological, and neurochemical effects of 
somatostatins (Somatostatin-14 and Somatostatin-28). The first 
indications of behavioral effects of these peptides were demon-
strated in monkeys (S i l e r  et al., 1973). In rats, the peptides 
influence self-stimulatory behavior (V é c s e i  et al., 1982), active 
(V é c s e i  et al., 1987) and passive (V é c s e i  et al., 1990a; 
R o m a n o v a  et al., 1990) avoidance behavior, and motor 
behavior (V é c s e i  et al., 1984) and display anti-amnestic action 
(V é c s e i  et al., 1983). A thiamine-difficient diet significantly 
impaired avoidance learning in proportion to decrease of SST flu-
orescence intensity in several brain regions (N a k a g a w a s a i 
et al., 2000a; N a k a g a w a s a i  et al., 2003). It also has been 
demonstrated that brain somatostatin is one of the most severely 
affected systems in patients with Alzheimer′s disease (D a v i e s , 
1980; V é c s e i  and K l i v é n y i , 1995), suggesting its pos-
sible involvement in the memory deficit of these patients. FK 962 
improved the memory impairments in rats through a possible 
potentiation of hippocampal somatostatinergic neurotransmis-
sion (T o k i t a  et al. ,  2005). This study strengthens the view 
that FK962 might be of therapeutic value against dementing 
disorders such as Alzheimer’s disease or senile dementia of the 
Alzheimer’s type.
The aim of the present study was to examine the effects of 
two different doses (0.5 and 1 µg) of SRIH-14 on  learning and 
acquisition of learning in adult female rats. 
Adult female Wistar rats weighing 210-230 g at the time 
of operation were implanted with a headset (later serving for 
i.c.v. injections) under ether anaesthesia. A minimum recovery 
period of 5 days was permitted before the onset of experiments. 
The animals were divided into three experimental groups, each 
including 8 rats. The first (I) and second (II) groups consisted of 
rats given a single i.c.v. injection of 0.5 or 1.0 μg of SRIH-14 (S9129; 
Sigma, St. Louis, MO. USA) in 5 μL of saline, respectively, three 
times every 48 hours. Rats of the third (III) (control) group were 
treated in the same manner with an equal volume of saline 
alone. Learning in the rats was examined by testing of active 
avoidance of a painful stimulus in an automated "Shuttle box 
450" cage. A tone of 1000 Hz and 68 dB for a maximum of 10 s 
was used as the conditioned stimulus (CS). The unconditioned 
stimulus (US) was an electric shock (0.2 mA, 2 s) delivered 
through the grid floor of the cage to the paws of the rat. The CS 
was presented for 8 s or terminated as soon as the animal made 
the response. The rats were tested on five consecutive days, 30 
min after i.c.v. administration of 0.5 or 1.0 μg of SRIH-14 or 
saline on days 1, 3 and 5. Each day for five consecutive days, 10 
trials were performed with inter-trial intervals of 60 seconds. 
For adaptation to the cage environment, the animals were put 
in the cage 15 minutes before the testing. The number of cor-
rect answers (CARs – conditioned avoidance responses) out of 
10 trials per day was registered during the test performance. 
An answer was considered correct when the animal crossed 
the cage to the other side during the tone application to avoid 
the painful stimulus. The conditioned avoidance responses 
(CARs) from each rat were averaged per experimental group 
and standard deviation (SD) of the means was calculated. One-
way analysis of variance (ANOVA) was used to test differences 
between the days of treatment within each experimental group. 
A statistically significant difference was considered to be one 
with a probability of 5% and less. The effects of SRIH-14 on 
shuttle-box learning in female rats are presented in Fig. 1.
In the control group, we obtained an increase of condi-
tioned avoidance responses (CARs) from the first to the fifth 
experimental day, although these increases were not statistically 
significant (p>0.05). In group I (0.5 μg SRIH-14), there was a 
statistically significant increase of CARs (p < 0.05) on the fifth 
experimental day in comparison with the first and the second 
experimental day. In group II (1.0 μg SRIH-14), there was a 
statistically significant increase of CARs (p < 0.05) on the fifth 
experimental day only when compared to the first experimental 
day. As seen in Fig. 2, the total number of CARs for five con-
secutive days was increased in group II, but this increase was not 
statistically significant, probably due to considerable individual 
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variability within each experimental group. 
The present study evaluated the effect of SRIH-14 on 
active avoidance behavior in female rats. Also, the effects of two 
different doses of i.c.v. administered SRIH-14 were analyzed. 
Some previously reported data indicated that somatostatin-28, 
but not SRIH-14, influenced shuttle box learning in adult male 
rats (V é c s e i  et al., 1990a). Besides differences in the type of 
somatostatin used, sex differences should be also considered. 
All studies so far available were performed only in adult male 
rats (V é c s e i  and W i d e r l ö v  1990b; N a k a g a w a s a i , 
2000, 2003). Our previous studies (S t a r c e v i c  et al., 2000) 
on adult female rats demonstrated that i.c.v. applied SRIH-14 
and -28 exerted opposite effects on the immunohistochemical 
and morphometric characteristics of ACTH cells, as well as 
ACTH plasma levels. Since shuttle-box learning is a stressful 
learning paradigm, it is worth pointing out that i.c.v. applied 
SRIH-28, but not SRIH-14, exerted significant inhibitory effects 
on the function and morphometric characteristics of ACTH 
cells. Consequently, it is possible that SRIH-14, through its slight 
activation of the HPA axis, facilitates active avoidance learning 
in female rats.
In conclusion, our results obtained in female rats with both 
doses used support the hypothesis that SRIH-14 affects active 
avoidance behavior. Work involving specific pharmacological 
manipulation of central SRIH receptors must consider the SRIH 
type, doses, and sex differences in response to this peptide. Nev-
ertheless, these findings could lead to modulation of learning 
processes without alteration of physiological activity evoked by 
SRIH.
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Fig. 1. Effects of SRIH-14 on shuttle-box learning in female rats. All 
values are means ± SD, n=8 animals per group. Arrows indicate the 
day of peptide injection. * p<0.05 versus the first and second day of 0.5 













Fig. 2. Total number of CARS for five consecutive days in 
female rats; n=8 animals per group ± SD.
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